Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
View/ Open
Access
info:eu-repo/semantics/openAccessAttribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/Date
2024Author
Şenocak Taşçı, ElifOyan, Başak
Sönmez, Özlem
Mutlu, Arda Ulaş
Atçı, Muhammed Mustafa
Sakin, Abdullah
Öner, İrem
Yeşil Çınkır, Havva
Bozkurt, Mustafa
Metadata
Show full item recordCitation
Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. ... Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0Abstract
...
WoS Q Kategorisi
Q2Source
BMC CancerVolume
24Issue
1Collections
- Bildiri Koleksiyonu [515]
- PubMed İndeksli Yayınlar Koleksiyonu [4075]
- WoS İndeksli Yayınlar Koleksiyonu [6462]